C
Collate
Health Tech & Medtech · San Francisco, United States · Founded 2025
Platform that use AI to create and streamline paperwork for diagnostic, medical device, and drug development companies MoreLess
An AI-powered platform designed to automate and streamline the creation of documentation for drug development, medical device, and diagnostic companies. The company's mission is to expedite the delivery of life-saving innovations to patients by reducing the time and resources spent on paperwork and document editing. By handling the labor-intensive documentation process, from concept to market, it allows life sciences companies to focus on innovation and discovery. The platform is aimed at a variety of data practitioners and is built to manage and ensure high-quality data assets.
Collate has secured $30 million in a seed funding round, which will support its growth and the development of its AI-powered solutions. The company's services are targeted at the life sciences industry, and it operates within the healthcare technology market, providing a unified platform for data discovery, observability, and governance.
Keywords: AI in healthcare, life sciences, documentation automation, medical devices, drug development, diagnostics, data governance, data discovery, regulatory compliance, healthcare technology
Talent graph
Collate's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Collate has talent and traffic
team presence
Market sentiment
What the market is saying about Collate
An AI-synthesized read of the highest-engagement posts about Collate on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Collate on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.



